Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Doxazosin for Psychostimulant Dependence
NCT01371851Phase 2Completed
- Sponsor
- University of Arkansas
- Start
- Jun 2011
- Primary completion
- May 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in methamphetamine use disorder (MUD) and cocaine dependence comparing Doxazosin with Placebo (2 arms). Primary endpoint: Change in Psychostimulant-positive Urines Over Time at 8 weeks. Started Jun 2011; status: completed.
02
Drugs
doxazosin
03
Conditions
methamphetamine use disorder (MUD)cocaine dependence
Beyond the preview
Go deeper on NCT01371851.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01371851.